Description:
Sepsis poses one of the greatest challenges in healthcare today, with approximately 1.7 million cases and 270,000 deaths annually in the United States alone. The condition is the most expensive to treat in US hospitals, highlighting the urgent need for effective diagnosis and treatment solutions. Kalorama Information’s report, Sepsis Diagnostics Products and Market Trends, provides an in-depth examination of the sepsis market, detailing current trends, emerging technologies, and the impact of COVID-19.
Key Features of the Report:
This comprehensive report offers valuable data and business planning resources, including:
- Sepsis Detection Practice Trends: Insights into current practices for detecting sepsis.
- Sepsis-Related Biomarkers: Analysis of biomarkers, their advantages, and disadvantages.
- Market Overview: Detailed market analysis for sepsis-related testing.
- Technological Innovations: Examination of mass spectrometry and its application in sepsis diagnosis.
- COVID-19 Impact: Special focus on the interplay between COVID-19 and sepsis.
- Sepsis Testing Products: Categorized by technology, including POC, AST, Culture/ID, NGS, Host Response, and amp-free isothermal methods, along with their approval statuses.
Market Insights:
- Complexity of Sepsis Diagnosis: Despite being the gold standard, blood culture analysis is slow and labor-intensive. The overlap of sepsis with other infectious diseases necessitates a broad range of products and technologies.
- Rapid and Multiplexed Tests: Emphasis on the importance of rapid and multiplexed tests for effective sepsis diagnosis.
- Infectious Disease Diagnostics: While the report covers systems and products for diagnosing infectious diseases, it does not provide a comprehensive breakdown of all products in this category.
- Additional Tests: Overview of other relevant tests such as blood gases, bilirubin, creatinine, and platelets, which may be conducted based on clinical needs.
Competitive Landscape:
The report profiles key players in the sepsis diagnostics and treatment market, providing insights into their products, technologies, and market strategies.
COVID-19 Impact Analysis:
A dedicated section explores the significant impact of the COVID-19 pandemic on sepsis diagnosis and treatment, discussing the challenges and new opportunities arising from the pandemic.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
